AAAAAA

   
Results: 1-2 |
Results: 2
Elucidating the autoimmune and antitumor effector mechanisms of a treatment based on cytotoxic T lymphocyte antigen-4 blockade in combination with a B16 melanoma vaccine: Comparison of prophylaxis and therapy
Authors: van Elsas, A Sutmuller, RPM Hurwitz, AA Ziskin, J Villasenor, J Medema, JP Overwijk, W Restifo, NP Melief, CJM Offringa, R Allison, JP
Citation: A. Van Elsas et al., Elucidating the autoimmune and antitumor effector mechanisms of a treatment based on cytotoxic T lymphocyte antigen-4 blockade in combination with a B16 melanoma vaccine: Comparison of prophylaxis and therapy, J EXP MED, 194(4), 2001, pp. 481-489
Induction of tumor antigen-specific immunity in vivo by a novel vaccinia vector encoding safety-modified simian virus 40 T antigen
Authors: Xie, YC Hwang, C Overwijk, W Zeng, Z Eng, MH Mule, JJ Imperiale, MJ Restifo, NP Sanda, MG
Citation: Yc. Xie et al., Induction of tumor antigen-specific immunity in vivo by a novel vaccinia vector encoding safety-modified simian virus 40 T antigen, J NAT CANC, 91(2), 1999, pp. 169-175
Risultati: 1-2 |